MCMULLIN KIRK 4

Accession 0001181431-12-031533

CIK 0000930553other

View on SEC.gov Company Profile

Filed

May 20, 8:00 PM ET

Accepted

May 21, 8:02 PM ET

Size

44.0 KB

Accession

0001181431-12-031533

Insider Transaction Report

Form 4

Period: 2012-05-17

ISTA PHARMACEUTICALS INCISTA

MCMULLIN KIRK

VP, Operations

Transactions

Tax Payment
Common Stock
2012-05-17$9.06/sh−11,424$103,501→ 75,911 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−7,229$65,495→ 87,449 total
Exercise/Conversion
Common Stock
2012-05-17$7.43/sh+13,571$100,833→ 104,476 total
Exercise/Conversion
Common Stock
2012-05-17$6.90/sh+15,000$103,500→ 87,335 total
Exercise/Conversion
Common Stock
2012-05-17$6.77/sh+13,673$92,566→ 101,122 total
Exercise/Conversion
Common Stock
2012-05-17$3.63/sh+12,395$44,994→ 126,204 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−12,396$112,308→ 6,564 total
Exercise: $1.04From: 2009-03-03Exp: 2019-02-03→ Common Stock (12,396 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−18,767$170,029→ 0 total
Exercise: $3.49From: 2003-01-16Exp: 2012-12-16→ Common Stock (18,767 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−4,452$40,335→ 25,189 total
Exercise: $6.82From: 2011-03-07Exp: 2021-02-07→ Common Stock (4,452 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−15,000$135,900→ 0 total
Exercise: $6.90From: 2003-08-05Exp: 2012-08-05→ Common Stock (15,000 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−13,571$122,953→ 0 total
Exercise: $7.43From: 2007-03-02Exp: 2017-02-02→ Common Stock (13,571 underlying)
Tax Payment
Common Stock
2012-05-17$9.06/sh−1,423$12,892→ 113,809 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−4,966$44,992→ 121,238 total
Exercise/Conversion
Common Stock
2012-05-17$3.49/sh+18,767$65,497→ 94,678 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−10,217$92,566→ 90,905 total
Exercise/Conversion
Common Stock
2012-05-17$4.46/sh+18,689$83,353→ 112,036 total
Exercise/Conversion
Common Stock
2012-05-17$1.04/sh+12,396$12,892→ 115,232 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−18,689$169,322→ 0 total
Exercise: $4.46From: 2008-03-08Exp: 2018-02-08→ Common Stock (18,689 underlying)
Tax Payment
Common Stock
2012-05-17$9.06/sh−11,129$100,829→ 93,347 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−9,200$83,352→ 102,836 total
Exercise/Conversion
Common Stock
2012-05-17$6.82/sh+4,452$30,363→ 125,690 total
Tax Payment
Common Stock
2012-05-17$9.06/sh−3,351$30,360→ 122,339 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−12,395$112,299→ 15,314 total
Exercise: $3.63From: 2010-03-02Exp: 2020-02-02→ Common Stock (12,395 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-17$9.06/sh−13,673$123,877→ 0 total
Exercise: $6.77From: 2006-03-16Exp: 2016-02-16→ Common Stock (13,673 underlying)

Footnotes (1)

[F1]Mr. McMullin exercised options for 108,943 of Issuer's shares under his Employee Stock Option (as shown in Table II of this Form 4). Of that amount, Mr. McMullin elected to have the Issuer withhold 58,939 shares to cover the exercise price in connection with the exercise of his Employee Stock Option (as shown in Table II of the Form 4). Mr. McMullin continues to hold the net remaining amount of 50,004 shares.

Documents

1 file

4
rrd346076.xmlPrimary
4

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

→

Entity typeother

Related Parties

filerCIK 0001216985

Filing Metadata

Form type: 4
Filed: May 20, 8:00 PM ET
Accepted: May 21, 8:02 PM ET
Size: 44.0 KB

View on SEC.gov